放射治疗激活前药物:过去,现在和以后
Changlun Wang1,2, Zihang Zhang2, Zhibo Liu1,2,3,4
1Peking University-Tsinghua University Center for Life Sciences, Peking University, Beijing 100871, China.
ACS central science
|September 2, 2025
概括
放射治疗激活前药物 (RAP) 提供向癌症治疗,仅在暴露于电离辐射时释放活性药物. 这种方法通过尽量减少非目标效应来提高治疗效率和患者的存活率.
科学领域:
- 癌症学
- 放射化学
- 提供药物
背景情况:
- 放射治疗与化疗结合显示出协同作用的抗瘤作用.
- 放射治疗激活前药物 (RAP) 正成为一种新的治疗策略.
- 在激活之前,RAP具有低毒性,辐射后具有向效果.
研究的目的:
- 总结放射治疗激活前药物 (RAP) 的最新进展.
- 讨论电离辐射的机制,类型,化学结构和前期药物形式.
- 突出目前的挑战和RAP研究的未来方向.
主要方法:
- 关于RAP的科学文献的审查.
- 分析涉及水放射解的RAP机制.
- 根据电离辐射类型,化学结构和格式对RAP进行分类.
主要成果:
- RAP使用水放射溶解中的活性物种释放活性药物.
- 已开发出多种化学结构和前期药物格式.
- 该领域包括用于前药激活的各种电离辐射类型.
结论:
- RAP是针对癌症治疗的一种有前途的方法.
- 需要进一步的研究来应对当前的挑战,并优化RAP的发展.
- RAP有潜力显著改善患者在放射治疗中的结果.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Prodrugs
2.8K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.8K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K


